Funding
Annual Funding
The total funding of the Cancer Research UK Cambridge Institute for 2025/26 is £43.8 million.
We are one of four Cancer Research UK institutes, receiving £25.8 million in 2025/26 of core funding from the charity. This core funding enables the Institute to provide an outstanding environment in which to train and develop scientists. The award supports our core facilities and allows Research Group Leaders to expand their teams and explore innovative new ideas.
Along with the core funding, the research in the Institute is funded by a number of organisations. We currently have 150 active research grants at the Institute totalling £18 million, with £6.6 million received from Cancer Research UK and the remainder from many other funding bodies.
Support our research
Our work is already making a positive impact for patients and their families.
Research here has led to personalised treatment programmes for patients in Cambridge and beyond. From developing innovative diagnostic tests to advancing imaging methods, we are translating our findings into clinical practice.
All of this has been made possible through philanthropy and generous donations from the public, whether through one of our funders or directly to the Institute.
If you would like to donate to cancer research in Cambridge, you can either donate online, or if you would like to send us a cheque please make it payable to the University of Cambridge and post to:
Grants and Finance
Cancer Research UK Cambridge Institute
University of Cambridge
Li Ka Shing Centre
Robinson Way
Cambridge
With thanks to all the organisations funding research at the Institute:
Academy of Medical Sciences
Addenbrooke’s Charitable Trust (ACT)
Alan Turing Institute
Altos Labs UK Ltd.
American Association for Cancer Research (AACR)
AstraZeneca
BBSRC
Blood Cancer UK
Boehringer Ingelheim Fonds
Brain Research UK
Brain Tumour Charity
Breast Cancer Now
Cancer-Africa ALBORADA Fund
Cancer Research Institute
Cancer Research Technology (CRT)
CCC
Cancer Research UK
Earlier.org
EC H2020
EC Horizon Europe
EPSRC
European Society of Medical Oncology (ESMO)
GE Medical Systems Ltd
GSK
HFSP
Little Princess Trust
Mark Foundation
Masason Foundation
The Minderoo Foundation
Medical Research Council
NC3Rs
Pancreatic Cancer UK
Royal Society
The Branco Weiss Fellowship (ETH Zurich)
UKRI
US Army
Varsity Pharmaceuticals Limited
Wellbeing of Women
Wellcome
Wellcome Trust Leap Inc.